Literature DB >> 11093735

Mechanisms of ischemic injury are different in the steatotic and normal rat liver.

M Selzner1, H A Rüdiger, D Sindram, J Madden, P A Clavien.   

Abstract

Hepatic steatosis is associated with significant morbidity and mortality after liver resection and transplantation. Although apoptosis is a key mechanism of reperfusion injury in the normal liver, the pathway leading to cell death in steatotic hepatocytes is unknown. A model of hepatic ischemia and reperfusion injury in fatty and lean Zucker rats was used. Fatty animals had increased aspartate aminotransferase (AST) release and decreased survival after 60 minutes of ischemia compared with lean animals. Apoptosis was the predominant form of cell death in the lean rats (82%), whereas necrosis was minimal. In contrast, fatty animals developed only moderate amounts of apoptosis but showed massive necrosis (73%) after 24 hours of reperfusion. Intracellular mediators of apoptosis, such as caspase 8, caspase 3, and cytochrome c, were significantly lower in the steatotic than in the lean liver indicating dysfunction in activation of the apoptotic pathway. The high percentage of necrosis in the steatotic rats was associated with renal acute tubular necrosis after 24 hours of reperfusion in the fatty, but not in lean rats. Caspase inhibition significantly decreased reperfusion injury in lean animals, but was ineffective in fatty animals. The results indicate that the increased susceptibility of fatty livers to reperfusion injury is associated with a change from an apoptotic form of cell death to necrosis. We conclude that new therapeutic strategies are necessary in the fatty liver.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093735     DOI: 10.1053/jhep.2000.20528

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  73 in total

1.  Intermittent ischaemia maintains function after ischaemia reperfusion in steatotic livers.

Authors:  Mathilde Steenks; Mark C P M van Baal; Vincent B Nieuwenhuijs; Menno T de Bruijn; Marc Schiesser; Mike H Teo; Tom Callahan; Rob T A Padbury; Greg J Barritt
Journal:  HPB (Oxford)       Date:  2010-05       Impact factor: 3.647

Review 2.  Pathophysiological Changes During Ischemia-reperfusion Injury in Rodent Hepatic Steatosis.

Authors:  Anna-Aikaterini Neri; Ismene A Dontas; Dimitrios C Iliopoulos; Theodore Karatzas
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

3.  Ischemia-reperfusion injury in rat steatotic liver is dependent on NFκB P65 activation.

Authors:  Sabarinathan Ramachandran; Jane M Liaw; Jianluo Jia; Sean C Glasgow; Wei Liu; Krista Csontos; G A Upadhya; T Mohanakumar; William C Chapman
Journal:  Transpl Immunol       Date:  2012-01-21       Impact factor: 1.708

4.  Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts.

Authors:  Christopher D Anderson; Gundumi Upadhya; Kendra D Conzen; Jianlou Jia; Elizabeth M Brunt; Venkataswarup Tiriveedhi; Yan Xie; Sabarinathan Ramachandran; Thalachallour Mohanakumar; Nicholas O Davidson; William C Chapman
Journal:  Liver Transpl       Date:  2011-02       Impact factor: 5.799

5.  Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.

Authors:  Vijay Subramanian; Anil B Seetharam; Neeta Vachharajani; Venkataswarup Tiriveedhi; Nataraju Angaswamy; Sabarinathan Ramachandran; Jeffrey S Crippin; Surendra Shenoy; William C Chapman; Thalachallour Mohanakumar; Christopher D Anderson
Journal:  Transplantation       Date:  2011-12-15       Impact factor: 4.939

6.  Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat.

Authors:  Anna Serafín; Joan Roselló-Catafau; Neus Prats; Carme Xaus; Emilio Gelpí; Carmen Peralta
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

7.  The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury.

Authors:  Kim H H Liss; Kyle S McCommis; Kari T Chambers; Terri A Pietka; George G Schweitzer; Sara L Park; Ilke Nalbantoglu; Carla J Weinheimer; Angela M Hall; Brian N Finck
Journal:  Liver Transpl       Date:  2018-07       Impact factor: 5.799

8.  CD47 blockade reduces ischemia/reperfusion injury and improves survival in a rat liver transplantation model.

Authors:  Zhen-Yu Xiao; Babak Banan; Jianluo Jia; Pamela T Manning; Ronald R Hiebsch; Muthukumar Gunasekaran; Gundumi A Upadhya; William A Frazier; Thalachallour Mohanakumar; Yiing Lin; William C Chapman
Journal:  Liver Transpl       Date:  2015-01-29       Impact factor: 5.799

9.  N-acetylcysteine administration does not improve patient outcome after liver resection.

Authors:  Stuart M Robinson; Rehan Saif; Gourab Sen; Jeremy J French; Bryon C Jaques; Richard M Charnley; Derek M Manas; Steven A White
Journal:  HPB (Oxford)       Date:  2013-01-07       Impact factor: 3.647

10.  Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice.

Authors:  Hiroyuki Kato; Sergio Duarte; Mary G Miller; Ronald W Busuttil; Ana J Coito
Journal:  Liver Transpl       Date:  2019-02       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.